[1] Singhal, B.S. (1985) Multiple Sclerosis-Indian Experience. Annals of the Academy of Medicine, Singapore, 14, 32-36.
[2] Chopra, J.S., Radhakrishnan, K., Sawhney, B.B., et al. (1980) Multiple Sclerosis in North-West India. Acta Neurologica Scandinavica, 62, 312-321.
http://dx.doi.org/10.1111/j.1600-0404.1980.tb03042.x
[3] Jain, S. and Maheshwari, M.C. (1985) Multiple Sclerosis: Indian Experience in the Last Thirty Years. Neuroepidemiology, 4, 96-107.
http://dx.doi.org/10.1159/000110220
[4] Gangopadhyay, G., Das, S.K., Sarda, P., et al. (1999) Clinical Profile of Multiple Sclerosis in Bengal. Neurology India, 47, 18-21.
[5] Tremlett, H.L., Luscombe, D.K. and Wiles, C.M. (1998) Use of Corticosteroids in Multiple Sclerosis by Consultant Neurologists in the United Kingdom. Journal of Neurology, Neurosurgery & Psychiatry, 65, 362-365.
http://dx.doi.org/10.1136/jnnp.65.3.362
[6] Henze, T., Riekmann, P. and Toyka, K.V. (2006) Symptomatic Treatment of Multiple Sclerosis-Multiple Sclerosis Therapy Consensus Group (MSTCG) of the German Multiple Sclerosis Society. European Neurology, 56, 78-105.
http://dx.doi.org/10.1159/000095699